NCT04005261View on ClinicalTrials.gov

C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

February 1, 2019

Study Completion Date

March 1, 2019

Conditions
Type 2 Diabetes Treated With Insulin
Interventions
DIAGNOSTIC_TEST

C-peptide concentrations

The patients will be grouped by their C-peptide concentrations

Trial Locations (1)

Unknown

IMU Goztepe Education and Research Hospital, Istanbul

All Listed Sponsors
lead

Goztepe Training and Research Hospital

OTHER

NCT04005261 - C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is it Time to Revise the Treatment of Type 2 Diabetes | Biotech Hunter | Biotech Hunter